Encellin, Inc.

United States of America

Back to Profile

1-15 of 15 for Encellin, Inc. Sort by
Query
Aggregations
IP Type
        Patent 12
        Trademark 3
Jurisdiction
        United States 7
        World 4
        Canada 4
Date
2025 1
2024 3
2023 4
2022 3
2021 2
See more
IPC Class
A61L 27/56 - Porous or cellular materials 8
A61K 35/39 - PancreasIslets of Langerhans 7
A61K 38/28 - Insulins 5
A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof 4
A41D 13/11 - Protective face masks, e.g. for surgical use, or for use in foul atmospheres 3
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 3
10 - Medical apparatus and instruments 3
Status
Pending 10
Registered / In Force 5

1.

METHODS AND DEVICES FOR PRE-VASCULARIZATION OF IMPLANTATION SITES AND/OR CELL ENCAPSULATION DEVICES

      
Application Number 18735879
Status Pending
Filing Date 2024-06-06
First Publication Date 2025-05-08
Owner Encellin, Inc. (USA)
Inventor
  • Nyitray, Crystal
  • Wei, Grace

Abstract

Provided herein are devices and methods for improved oxygenation of biological cells transplanted into a biological subject. The devices and methods may be used to promote vascularization to a transplantation site of the biological subject, and/or may be used to improve survival and functionality of cells contained within an encapsulation device.

IPC Classes  ?

  • A61F 2/02 - Prostheses implantable into the body
  • A61F 2/00 - Filters implantable into blood vesselsProstheses, i.e. artificial substitutes or replacements for parts of the bodyAppliances for connecting them with the bodyDevices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61L 27/34 - Macromolecular materials
  • A61L 27/56 - Porous or cellular materials
  • C08L 67/04 - Polyesters derived from hydroxy carboxylic acids, e.g. lactones

2.

CELL ENCAPULATION DEVICES AND METHODS OF USING SAME

      
Application Number 18753578
Status Pending
Filing Date 2024-06-25
First Publication Date 2024-12-26
Owner ENCELLIN, INC. (USA)
Inventor
  • Nyitray, Crystal
  • Wei, Grace

Abstract

Disclosed herein are devices for encapsulating biological cells and are suitable to be implanted into a subject. In different aspects of the disclosure, the devices may comprise a plurality of polymer layers. In one aspect, a device comprises a first polymer layer and a second polymer layer. In some cases, the first polymer layer may be a nanoporous polymer layer. In some cases, the second polymer layer may be a macroporous polymer layer. The first and second polymer layers may define a lumen for enclosing a population of cells. The devices may be used to transplant cells producing therapeutic agents into a subject (e.g., for the treatment of a disease).

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61K 35/39 - PancreasIslets of Langerhans
  • A61K 38/28 - Insulins
  • A61L 27/18 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances
  • A61L 27/56 - Porous or cellular materials

3.

ENCRX

      
Serial Number 98366145
Status Pending
Filing Date 2024-01-19
Owner Encellin, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical products for treatment of chronic diseases by means of gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for implantable cell therapy; living cells for gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for medical use, namely, encapsulated cells delivered by implantable cell therapy devices for secreting drugs and/or molecules; encapsulated pharmaceutical products for the treatment of chronic diseases; implantable pharmaceutical products for the treatment of chronic diseases; encapsulated pharmaceutical product for the treatment of chronic diseases delivered by implantable encapsulation devices with encapsulated cells for secreting drugs Cell encapsulation devices in the nature of implantable drug and/or molecule and cell therapy delivery ports; implantable cell encapsulation devices in the nature of implantable drug and/or molecule and cell therapy delivery ports; implantable cell therapy devices in the nature of implantable drug and/or molecule and cell therapy delivery ports; drug and prescription encapsulation devices in the nature of implantable drug and cell therapy delivery ports; implantable drug and prescription encapsulation devices in the nature of implantable drug and cell therapy delivery ports; implantable drug and prescription delivery devices in the nature of implantable drug and cell therapy delivery ports

4.

ENCRT

      
Application Number 230433800
Status Registered
Filing Date 2024-01-09
Registration Date 2026-03-25
Owner Encellin, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Pharmaceutical preparations for use in gene and cell therapy; pharmaceutical products in the nature of encapsulated living cells for gene and cell therapy; biological preparations made from living cells for use in cell therapy; biological preparations made from living cells for use in cell therapy in the nature of implantable living cells. (2) Cell encapsulation medical devices in the nature of a nano-porous polymeric pouch designed to encapsulate therapeutic cells for delivery to human organs; implantable medical devices in the nature of nano-porous, polymeric pouches designed to encapsulate therapeutic cells and be implanted subcutaneously; nano-parous polymeric implants in the nature of pouches containing encapsulated therapeutic cells.

5.

ENCRT

      
Serial Number 98333363
Status Pending
Filing Date 2023-12-28
Owner Encellin, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical products for treatment of chronic diseases by means of gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for implantable cell therapy; living cells for gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for medical use, namely, implantable cell therapy preparations with encapsulated cells for secreting drugs and/or molecules Cell encapsulation devices in the nature of implantable cell therapy delivery ports; implantable cell encapsulation devices in the nature of implantable cell therapy delivery ports; implantable cell therapy devices in the nature of implantable cell therapy delivery ports

6.

CELL ENCAPSULATION DEVICES AND METHODS OF USING SAME

      
Application Number 18023578
Status Pending
Filing Date 2021-09-16
First Publication Date 2023-10-05
Owner ENCELLIN, INC. (USA)
Inventor
  • Nyitray, Crystal
  • Wei, Grace

Abstract

Disclosed herein are devices for encapsulating biological cells and are suitable to be implanted into a subject. In different aspects of the disclosure, the devices may comprise a plurality of polymer layers. In one aspect, a device comprises a first polymer layer and a second polymer layer. In some cases, the first polymer layer may be a nanoporous polymer layer. In some cases, the second polymer layer may be a macroporous polymer layer. The first and second polymer layers may define a lumen for enclosing a population of cells. In some cases, the device further comprises a third polymer layer. The devices may be used to transplant cells producing therapeutic agents into a subject (e.g., for the treatment of a disease).

IPC Classes  ?

  • A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
  • C08G 63/08 - Lactones or lactides
  • A61K 35/39 - PancreasIslets of Langerhans
  • A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

7.

METHODS AND DEVICES FOR PRE-VASCULARIZATION OF IMPLANTATION SITES AND/OR CELL ENCAPSULATION DEVICES

      
Application Number US2022052413
Publication Number 2023/107698
Status In Force
Filing Date 2022-12-09
Publication Date 2023-06-15
Owner ENCELLIN, INC. (USA)
Inventor
  • Nyitray, Crystal
  • Wei, Grace

Abstract

Provided herein are devices and methods for improved oxygenation of biological cells transplanted into a biological subject. The devices and methods may be used to promote vascularization to a transplantation site of the biological subject, and/or may be used to improve survival and functionality of cells contained within an encapsulation device.

IPC Classes  ?

  • A61F 2/02 - Prostheses implantable into the body
  • A61F 2/00 - Filters implantable into blood vesselsProstheses, i.e. artificial substitutes or replacements for parts of the bodyAppliances for connecting them with the bodyDevices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61L 27/18 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
  • A61L 27/38 - Animal cells
  • A61L 27/56 - Porous or cellular materials
  • A61M 37/00 - Other apparatus for introducing media into the bodyPercutany, i.e. introducing medicines into the body by diffusion through the skin
  • B32B 27/36 - Layered products essentially comprising synthetic resin comprising polyesters
  • C12M 1/12 - Apparatus for enzymology or microbiology with sterilisation, filtration, or dialysis means
  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/071 - Vertebrate cells or tissues, e.g. human cells or tissues
  • C12N 11/096 - PolyestersPolyamides

8.

RESPIRATOR FACE MASKS FOR PROTECTION FROM AIRBORNE PARTICLES

      
Application Number 17914004
Status Pending
Filing Date 2021-03-25
First Publication Date 2023-04-27
Owner ENCELLIN, INC. (USA)
Inventor
  • Nyitray, Crystal
  • Wei, Grace

Abstract

The present disclosure provides a filtration media for filtering one or more airborne particles. The filtration media may comprise a membrane comprising one or more polymeric layers to filter the airborne particles. The filtration media may have high filtration efficiency and high breathability. Additionally, the present disclosure provides devices (e.g., face masks) comprising the filtration media which may be used to filter airborne particles (e.g., bacteria, viruses) and to protect the wearer (e.g., from infection).

IPC Classes  ?

  • A61L 9/012 - Deodorant compositions characterised by being in a special form, e.g. gels, emulsions
  • A41D 13/11 - Protective face masks, e.g. for surgical use, or for use in foul atmospheres
  • A61L 9/014 - Deodorant compositions containing sorbent material, e.g. activated carbon
  • A62B 23/02 - Filters for breathing-protection purposes for respirators
  • B01D 46/54 - Particle separators, e.g. dust precipitators, using ultra-fine filter sheets or diaphragms
  • B01D 71/06 - Organic material
  • B01D 69/12 - Composite membranesUltra-thin membranes
  • B01D 69/02 - Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or propertiesManufacturing processes specially adapted therefor characterised by their properties

9.

CELL ENCAPSULATION DEVICES AND METHODS OF USING SAME

      
Application Number 17437998
Status Pending
Filing Date 2020-03-11
First Publication Date 2022-06-02
Owner ENCELLIN, INC. (USA)
Inventor
  • Nyitray, Crystal
  • Wei, Grace

Abstract

Disclosed herein are devices for encapsulating biological cells and are suitable to be implanted into a subject. In different aspects of the disclosure, the devices may comprise a plurality of polymer layers. In one aspect, a device comprises a first polymer layer and a second polymer layer. In some cases, the first polymer layer may be a nanoporous polymer layer. In some cases, the second polymer layer may be a macroporous polymer layer. The first and second polymer layers may define a lumen for enclosing a population of cells. The devices may be used to transplant cells producing therapeutic agents into a subject (e.g., for the treatment of a disease).

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61K 38/28 - Insulins
  • A61K 35/39 - PancreasIslets of Langerhans
  • A61L 27/18 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
  • A61L 27/56 - Porous or cellular materials
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances

10.

CELL ENCAPSULATION DEVICES AND METHODS OF USING SAME

      
Document Number 03191594
Status Pending
Filing Date 2021-09-16
Open to Public Date 2022-03-24
Owner ENCELLIN, INC. (USA)
Inventor
  • Nyitray, Crystal
  • Wei, Grace

Abstract

Disclosed herein are devices for encapsulating biological cells and are suitable to be implanted into a subject. In different aspects of the disclosure, the devices may comprise a plurality of polymer layers. In one aspect, a device comprises a first polymer layer and a second polymer layer. In some cases, the first polymer layer may be a nanoporous polymer layer. In some cases, the second polymer layer may be a macroporous polymer layer. The first and second polymer layers may define a lumen for enclosing a population of cells. In some cases, the device further comprises a third polymer layer. The devices may be used to transplant cells producing therapeutic agents into a subject (e.g., for the treatment of a disease).

IPC Classes  ?

  • A61K 35/39 - PancreasIslets of Langerhans
  • A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/56 - Porous or cellular materials
  • A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
  • B32B 7/05 - Interconnection of layers the layers not being connected over the whole surface, e.g. discontinuous connection or patterned connection
  • C08L 67/04 - Polyesters derived from hydroxy carboxylic acids, e.g. lactones

11.

CELL ENCAPSULATION DEVICES AND METHODS OF USING SAME

      
Application Number US2021050705
Publication Number 2022/061007
Status In Force
Filing Date 2021-09-16
Publication Date 2022-03-24
Owner ENCELLIN, INC. (USA)
Inventor
  • Nyitray, Crystal
  • Wei, Grace

Abstract

Disclosed herein are devices for encapsulating biological cells and are suitable to be implanted into a subject. In different aspects of the disclosure, the devices may comprise a plurality of polymer layers. In one aspect, a device comprises a first polymer layer and a second polymer layer. In some cases, the first polymer layer may be a nanoporous polymer layer. In some cases, the second polymer layer may be a macroporous polymer layer. The first and second polymer layers may define a lumen for enclosing a population of cells. In some cases, the device further comprises a third polymer layer. The devices may be used to transplant cells producing therapeutic agents into a subject (e.g., for the treatment of a disease).

IPC Classes  ?

  • A61L 27/56 - Porous or cellular materials
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • B32B 27/36 - Layered products essentially comprising synthetic resin comprising polyesters
  • B32B 3/26 - Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shapeLayered products comprising a layer having particular features of form characterised by a particular shape of the outline of the cross-section of a continuous layerLayered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shapeLayered products comprising a layer having particular features of form characterised by a layer with cavities or internal voids
  • B32B 7/05 - Interconnection of layers the layers not being connected over the whole surface, e.g. discontinuous connection or patterned connection
  • C08L 67/04 - Polyesters derived from hydroxy carboxylic acids, e.g. lactones
  • A61K 35/39 - PancreasIslets of Langerhans
  • A61K 38/28 - Insulins
  • A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/071 - Vertebrate cells or tissues, e.g. human cells or tissues

12.

RESPIRATOR FACE MASKS FOR PROTECTION FROM AIRBORNE PARTICLES

      
Document Number 03173482
Status Pending
Filing Date 2021-03-25
Open to Public Date 2021-09-30
Owner ENCELLIN, INC. (USA)
Inventor
  • Nyitray, Crystal
  • Wei, Grace

Abstract

The present disclosure provides a filtration media for filtering one or more airborne particles. The filtration media may comprise a membrane comprising one or more polymeric layers to filter the airborne particles. The filtration media may have high filtration efficiency and high breathability. Additionally, the present disclosure provides devices (e.g., face masks) comprising the filtration media which may be used to filter airborne particles (e.g., bacteria, viruses) and to protect the wearer (e.g., from infection).

IPC Classes  ?

  • A41D 13/11 - Protective face masks, e.g. for surgical use, or for use in foul atmospheres
  • A62B 18/02 - Masks
  • A62B 23/02 - Filters for breathing-protection purposes for respirators
  • B01D 39/16 - Other self-supporting filtering material of organic material, e.g. synthetic fibres
  • B01D 69/12 - Composite membranesUltra-thin membranes
  • B01D 71/06 - Organic material

13.

RESPIRATOR FACE MASKS FOR PROTECTION FROM AIRBORNE PARTICLES

      
Application Number US2021024131
Publication Number 2021/195365
Status In Force
Filing Date 2021-03-25
Publication Date 2021-09-30
Owner ENCELLIN, INC. (USA)
Inventor
  • Nyitray, Crystal
  • Wei, Grace

Abstract

The present disclosure provides a filtration media for filtering one or more airborne particles. The filtration media may comprise a membrane comprising one or more polymeric layers to filter the airborne particles. The filtration media may have high filtration efficiency and high breathability. Additionally, the present disclosure provides devices (e.g., face masks) comprising the filtration media which may be used to filter airborne particles (e.g., bacteria, viruses) and to protect the wearer (e.g., from infection).

IPC Classes  ?

  • B01D 39/16 - Other self-supporting filtering material of organic material, e.g. synthetic fibres
  • A62B 18/02 - Masks
  • A62B 23/02 - Filters for breathing-protection purposes for respirators
  • A41D 13/11 - Protective face masks, e.g. for surgical use, or for use in foul atmospheres
  • B01D 69/12 - Composite membranesUltra-thin membranes
  • B01D 71/06 - Organic material

14.

CELL ENCAPSULATION DEVICES AND METHODS OF USING SAME

      
Document Number 03131950
Status Pending
Filing Date 2020-03-11
Open to Public Date 2020-09-17
Owner ENCELLIN, INC. (USA)
Inventor
  • Nyitray, Crystal
  • Wei, Grace

Abstract

Disclosed herein are devices for encapsulating biological cells and are suitable to be implanted into a subject. In different aspects of the disclosure, the devices may comprise a plurality of polymer layers. In one aspect, a device comprises a first polymer layer and a second polymer layer. In some cases, the first polymer layer may be a nanoporous polymer layer. In some cases, the second polymer layer may be a macroporous polymer layer. The first and second polymer layers may define a lumen for enclosing a population of cells. The devices may be used to transplant cells producing therapeutic agents into a subject (e.g., for the treatment of a disease).

IPC Classes  ?

  • A61K 35/39 - PancreasIslets of Langerhans
  • A61K 38/28 - Insulins
  • A61L 27/56 - Porous or cellular materials
  • A61M 5/00 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular wayAccessories therefor, e.g. filling or cleaning devices, arm rests
  • A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body

15.

CELL ENCAPSULATION DEVICES AND METHODS OF USING SAME

      
Application Number US2020022063
Publication Number 2020/185874
Status In Force
Filing Date 2020-03-11
Publication Date 2020-09-17
Owner ENCELLIN, INC. (USA)
Inventor
  • Nyitray, Crystal
  • Wei, Grace

Abstract

Disclosed herein are devices for encapsulating biological cells and are suitable to be implanted into a subject. In different aspects of the disclosure, the devices may comprise a plurality of polymer layers. In one aspect, a device comprises a first polymer layer and a second polymer layer. In some cases, the first polymer layer may be a nanoporous polymer layer. In some cases, the second polymer layer may be a macroporous polymer layer. The first and second polymer layers may define a lumen for enclosing a population of cells. The devices may be used to transplant cells producing therapeutic agents into a subject (e.g., for the treatment of a disease).

IPC Classes  ?

  • A61L 27/56 - Porous or cellular materials
  • A61K 38/28 - Insulins
  • A61K 35/39 - PancreasIslets of Langerhans
  • A61M 5/00 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular wayAccessories therefor, e.g. filling or cleaning devices, arm rests